COMP <GO>
HKPD vs COSM // OPERATING MARGIN
Cellyan Biotechnology Co. Ltd (Class A) (NASDAQ) VS. Cosmos Health Inc. (NASDAQ) • 15-METRIC TALLY: HKPD 0
— COSM 2
■ METRIC PARITY
LAST: $2.19 (+0.46%) • MKT CAP: $5.4M
operating-margins
—
LAST: $0.28 (+11.45%) • MKT CAP: $27.9M
operating-margins
-25.60%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HKPD VS. COSM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HKPD | COSM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 12.10% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | -35.00% | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin ACTIVE | — | -25.60% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -29.30% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 19.90% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 0.20 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | — | 3/9 | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 35.5 | 51.5 | -16.01 | COSM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.4M | $27.9M | -$22.5M | COSM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HKPD REV | COSM REV | HKPD GROSS % | COSM GROSS % | HKPD FCF | COSM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | — | $65.3M | — | 12.1% | — | -$8.5M |
| FY 2024 | — | $54.4M | — | 7.9% | — | -$8.1M |
| FY 2023 | — | $53.4M | — | — | — | -$15.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HKPD // BETA —
COSM // BETA —